Takeda Pharmaceuticals Korea released DPP-4 inhibitor, Nesina tablet for diabetes treatment in the d
(Yakup Shinmoon)
On Jan 3, Takeda Pharmaceuticals Korea announced that they released Nesina tablet (ingredient: alogliptin benzoate) for type 2 diabetes treatment in the domest...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
